Ghrelin, glucose homeostasis, and carotid intima media thickness in kidney transplantation

Transplantation

Volumn 84, Issue 10, 2007, Pages 1248-1254

  Genís, Beatriz Bayés ^a,b   Granada, Maria Luisa ^a   Alonso, Nuria ^a   Lauzurica, Ricardo ^a   Jiménez, Jose Angel ^a   Barluenga, Eva ^a   Homs, Mercedes ^a   Pastor, Mari Cruz ^a   Salinas, Isabel ^a   Quintero, Juan Carlos ^a   Sanmartí, Anna ^a   Romero, Ramon ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Adiponectin; C reactive protein; Carotid ultrasound; Ghrelin; Kidney transplant; Oral glucose tolerance test

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; GHRELIN; GLUCOSE; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ADULT; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; CONTROLLED STUDY; DIABETES MELLITUS; DOPPLER FLOWMETRY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GRAFT RECIPIENT; HUMAN; KIDNEY TRANSPLANTATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; BLOOD; CROSS-SECTIONAL STUDY; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; INTIMA; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUNICA MEDIA;

ATHEROSCLEROSIS; BLOOD GLUCOSE; CAROTID ARTERIES; CROSS-SECTIONAL STUDIES; FEMALE; GHRELIN; GLUCOCORTICOIDS; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; PREDNISONE; TUNICA INTIMA; TUNICA MEDIA;

EID: 38449095415     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000287456.82676.01     Document Type: Article

References (30)

1. Gonzalez-Posada JM, Hernandez D, Bayes Genis B, et al. Impact of diabetes mellitus on kidney transplant recipients in Spain. Nephrol Dial Transplant 2004; 19: iii57.
2. Armstrong KA, Prins JB, Beller EM, et al. Should an oral glucose tolerance test be performed routinely in all renal transplant recipients?. Clin J Am Soc Nephrol 2006; 1: 100.
3. Cosio FG, Kudva Y, van der Velde M, et al. New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int 2005; 67: 2415.
4. Ducloux D, Kazory A, Chalopin JM. Posttransplant diabetes mellitus and atherosclerotic events in renal transplant recipients: A prospective study. Transplantation 2005; 79: 438.
5. Kasiske BL, Chakkera HA, Roel J. Explained and unexplained ischemic heart disease risk after renal transplantation. J Am Soc Nephrol 2000; 11: 1735.
6. Rabinovitch A. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diabetes Metab Rev 1998; 14: 129.
7. Patel VB, Robbins MA, Topol EJ. C-reactive protein: A "golden marker" for inflammation and coronary artery disease. Cleve Clin J Med 2001; 68: 521.
8. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499.
9. Bayés B, Lauzurica R, Granada ML, et al. Adiponectin and risk of new-onset diabetes mellitus after kidney transplantation. Transplantation 2004; 78: 26.
10. Pischon T, Girman CJ, Hotamisligil GS, et al. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 2004; 291: 1730.
11. Ghigo E, Broglio F, Arvat E, et al. Ghrelin: More than a natural GH secretagogue and/or an orexigenic factor. Clin Endocrinol 2005; 62: 1.
12. O'Leary DH, Polak JF, Kronmal RA, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults: Cardiovascular Health Study. N Engl J Med 1999; 340: 14.
13. Diamantopoulos EJ, Andreadis EA, Tsourous GI, et al. Early vascular lesions in subjects with metabolic syndrome and prediabetes. Int Angiol 2006; 25: 179.
14. Standards of medical care in diabetes 2006. American Diabetes Association. Diabetes Care 2006; 29: S4.
15. Oterdoom L, de Vries A, van Son W, et al. Validation of insulin resistance indexes in a stable renal transplant population. Diabetes Care 2005; 28: 2424.
16. Junyent M, Gilabert R, Núñez I, et al. Ecografía carotídea en la evaluación de aterosclerosis preclínica. Distribución de valores del grosoríntima-media y frecuencia de placas de ateroma en una cohorte comunitaria española. Med Clin (Barc) 2005; 125: 770.
17. Hjelmesaeth J, Hartmann A, Leivestad T, et al. The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events. Kidney Int 2006; 69: 588.
18. Taubes G. Cardiovascular disease. Does inflammation cut to the heart of the matter? Science 2002; 296: 242.
19. Lee WY, Allison MA, Kim DJ, et al. Association of interleukin-6 and C-reactive protein with subclinical carotid atherosclerosis (the Rancho Bernardo Study). Am J Cardiol 2007; 99: 99.
20. Papagianni A, Kalovoulos M, Kirmizis D, et al. Carotid atherosclerosis is associated with inflammation and endothelial cell adhesion molecules in chronic haemodialysis patients. Nephrol Dial Transplant 2003; 18: 113.
21. Maahs DM, Ogden LG, Kinney GL, et al. Low plasma adiponectin levels predict progression of coronary artery calcification. Circulation 2005; 111: 747.
22. Hjelmesaeth J, Flyvbjerg A, Jenssen T, et al. Hypoadiponectinemia is associated with insulin resistance and glucose intolerance after renal transplantation: impact of immunosuppressive and antihypertensive drug therapy. Clin J Am Soc Nephrol 2006; 1: 575.
23. Tschop M, Weyer C, Tataranni PA, et al. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001; 50: 707.
24. Iglesias P, Díez JJ, Fernández-Reyes MJ, et al. Serum ghrelin concentrations in patients with chronic renal failure undergoing dialysis. Clin Endocrinol 2006; 64: 68.
25. Yoshimoto A, Mori K, Sugawara A, et al. Plasma ghrelin and desacyl ghrelin concentrations in renal failure. J Am Soc Nephrol 2002; 13: 2748.
26. Poykko SM, Kellokoski E, Horkko S, et al. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 2003; 52: 2546.
27. Ukkola O. Ghrelin and insulin metabolism. Eur J Clin Invest 2003; 33: 183.
28. Gauna C, Delhanty P, Hofland L, et al. Ghrelin and des-octanoyl ghrelin modulate glucose output by primary hepatocytes. Presented at The Endocrine Society's 86th Annual Meeting, June 16-19, 2004, New Orleans, LA.
29. García E, Korbonits M. Ghrelin and cardiovascular health. Curr Opin Pharmacol 2006; 6: 142.
30. Dixit VD, Schaffer EM, Pyle RS, et al. Ghrelin inhibits leptin-and activation- induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest 2004; 114: 57.